Home›Stock Screener›Dr Lalchandani Labs›Financial Statements

Dr Lalchandani Labs Complete Financial Statements

8 Years of Data
2025 - 2018

In FYNone, Dr Lalchandani Labs (DLCL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00. Full financial statements from FY2018 to FY2025 (8 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review DLCL P/E ratio to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

EBITDA Margin 20.00% 2025 data
Operating Margin 21.00% 2025 data

Balance Sheet Ratios

Equity Ratio 62.50% 2025 data
Asset Turnover 0.31 2025 data

DLCL Revenue, Net Profit & EBITDA — Year-on-Year Growth

DLCL YoY (March 2025 vs Period) — revenue -100.0%, EBITDA -100.0%, expenses -100.0%. For live price, earnings ratios and company overview, see Dr Lalchandani Labs screener.

Revenue Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+6.7%
Year-over-Year
Investing Cash Flow Growth
-100.0%
Year-over-Year
Financing Cash Flow Growth
+150.0%
Year-over-Year

DLCL Income Statement — Revenue, EBITDA & Net Profit

Dr Lalchandani Labs revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None). Explore DLCL value investing to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018
Revenue 0 5 5 5 11 10 6 5 3
Expenses 0 4 5 5 9 8 5 4 2
EBITDA 0 1 0 0 2 2 1 1 1
Operating Profit Margin % 0.00% 21.00% 4.00% 2.00% 21.00% 23.00% 21.00% 23.00% 22.00%
Depreciation 0 1 1 1 1 1 0 0 0
Interest 0 0 0 1 1 0 0 0 0
Profit Before Tax 0 0 1 -2 1 1 1 1 0
Tax 0 0 0 0 0 0 0 0 0
Net Profit 0 0 1 -2 1 1 1 1 0
Earnings Per Share (₹) 0.00 0.96 1.43 -3.61 2.15 2.33 1.09 1.23 0.89

DLCL Balance Sheet — Assets, Liabilities & Shareholders' Equity

DLCL total assets ₹16 Cr, total equity ₹10 Cr, total liabilities ₹ Cr (2025).

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018
ASSETS
Total Assets 16 15 18 18 15 12 10 6
Current Assets 11 10 11 11 9 8 6 4
Fixed Assets 4 4 5 6 5 4 3 2
Capital Work in Progress 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0
Other Assets 12 11 12 12 10 9 7 4
LIABILITIES
Total Liabilities
Current Liabilities 0 0 4 3 3 2 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 10 10 9 11 10 9 8 3
Share Capital 4 4 4 4 4 4 4 3
Reserves & Surplus 6 5 5 6 5 4 4 0

DLCL Cash Flow Statement — Operating, Investing & Financing

Dr Lalchandani Labs operating cash flow ₹0 Cr, investing ₹0 Cr, financing ₹1 Cr, net cash flow ₹1 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018
Operating Activities 0 0 0 2 1 0 0 1
Investing Activities 0 1 0 -2 -2 -1 -2 -1
Financing Activities 1 -2 0 0 2 1 4 2
Net Cash Flow 1 -1 0 1 1 0 1 1